San Diego

RiFT Biotherapeutics Wins Golden Ticket Sponsored by Boehringer Ingleheim

Wednesday, March 01, 2017

The hottest ticket in town, a 1 year membership with office and lab space at our San Diego location, went to biotech startup, RiFT Biotherapeutics. RiFT competed against more than dozen other bioinnovators for the Golden Ticket, sponsored by our friends at Boehringer Ingleheim.

Congratulations to Miguel de los Rios, Cory Bentley, Jeff Pitman and the entire RiFT team!

About RiFT Biotherapeutics

RiFT is a therapeutic antibody company focused on Immuno-Oncology targets outside of the T-cell space. Specifically, they target clinically implicated immune infiltrating cells in the inflammatory tumor microenvironment, such as myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs).